Loading data
KRMDNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 41.13 m USD | 33.65 m USD | 28.52 m USD | 27.9 m USD | 23.49 m USD |
| Cost of revenue | 15.52 m USD | 12.31 m USD | 11.81 m USD | 12.53 m USD | 9.72 m USD |
| Gross profit | 25.6 m USD | 21.33 m USD | 16.71 m USD | 15.37 m USD | 13.77 m USD |
| Research and development expense | 4.39 m USD | 5.26 m USD | 5.74 m USD | 4.96 m USD | 2.47 m USD |
| Selling, general and administrative expense | 23.38 m USD | 21.63 m USD | 20.37 m USD | 20.61 m USD | 17.86 m USD |
| Operating profit | -2.97 m USD | -6.45 m USD | -10.27 m USD | -10.78 m USD | -7.03 m USD |
| Profit before tax | -2.62 m USD | -6.06 m USD | — | — | — |
| Income tax expense | 21.89 k USD | 2.89 k USD | 3.97 m USD | -2.01 m USD | -1.8 m USD |
| Net income (reported basis) | -2.64 m USD | -6.07 m USD | -13.74 m USD | -8.66 m USD | -4.56 m USD |
| Basic earnings per share | -0.06 USD/share | -0.13 USD/share | -0.3 USD/share | -0.19 USD/share | -0.1 USD/share |
| Diluted earnings per share | -0.06 USD/share | -0.13 USD/share | -0.3 USD/share | -0.19 USD/share | -0.1 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.